simendan has been researched along with Dyspnea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Teerlink, JR | 1 |
| Albuquerque, D; Baima, J; Barretto, AC; Bocchi, EA; Lage, S; Moreira, Mda C; Rassi, S; Ribeiro, JP; Vilas-Boas, F | 1 |
1 review(s) available for simendan and Dyspnea
| Article | Year |
|---|---|
Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.
Topics: Acute Disease; Drug Approval; Dyspnea; Forecasting; Heart Failure; Hospitalization; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Pyridazines; Pyridines; Randomized Controlled Trials as Topic; Severity of Illness Index; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents | 2003 |
1 trial(s) available for simendan and Dyspnea
| Article | Year |
|---|---|
Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Brazil; Cardiotonic Agents; Dyspnea; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Hydrazones; Infusions, Intravenous; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Prospective Studies; Pyridazines; Quality of Life; Simendan; Treatment Outcome; Vasodilator Agents; Young Adult | 2008 |